MS

Manisha Singh

Active Director Director DIN 11784750
DIN 11784750 First appointment Jun 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Manisha Singh

Manisha Singh is a Director at Dr Cm Internal Medicine Private Limited (since 2026).

DIN 11784750
Primary Designation Director
First Appointment 22 Jun 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Jun 20262026Active

Board colleagues of Manisha Singh

NameDINCompanyDesignation
Chandra Mohan GuptaDr Cm Internal Medicine Private LimitedIndividual Subscriber
Shweta Shukla11784749Dr Cm Internal Medicine Private LimitedDirector/Designated Partner
U86100dc2026ptc472517Dr Cm Internal Medicine Private LimitedCompany/Llp

Directorship timeline

Open interactive timeline →
Dr Cm Internal Medicine Private Limited
Premium access

Shareholding and investment profile for Manisha Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manisha Singh

Manisha Singh currently holds 1 directorship: Dr Cm Internal Medicine Private Limited (Director, since 22 Jun 2026).

Manisha Singh was first appointed on 22 Jun 2026 as Director at Dr Cm Internal Medicine Private Limited.

The current boards of Manisha Singh's companies include Chandra Mohan Gupta (Dr Cm Internal Medicine Private Limited), Shweta Shukla (Dr Cm Internal Medicine Private Limited), U86100dc2026ptc472517 (Dr Cm Internal Medicine Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available